Stocks-ZTS-Zoetis

ZTS Zoetis

173.98 -0.03 (-0.02%)
Market ClosedDelayed Prices By NASDAQ, in USD
Trade

Zoetis price

-1.14% Past Week
Created with Highcharts 4.2.7 /Highstock 4.2.7
Market Cap
80.09B
Day’s Range
173.47
-
174.96
52W Range
123.89
-
194.59
Volume (3M)
1.77M
Price-Earnings Ratio
36.61
Revenue
8.22B

Zoetis Latest News

View All
Top Discussions
Selim Boukezouh
🔍 DownDetector 🤖 September 13th: 📉 NETFLIX INC | ★ ★ ★ ★ | -5.16% $NFLX (Netflix, Inc.) 🐾 Zoetis Inc. | ★ ★ ★ ★ ★ | -3.03% $ZTS (Zoetis) ⚙️ EMERSON ELECTRIC CO | ★ ★ ★ ★ | -2.24% $EMR (Emerson Electric Co) 🔬 IDEXX LABORATORIES INC | ★ ★ ★ ★ ★ | -2.5% $IDXX (IDEXX Laboratories Inc) 🖨️ HP INC... Show More
Like CommentShare
null
.
Jeroval
$ZTS (Zoetis) HSBC maintient sa recommandation d'achat Zoetis Inc. est spécialisé dans le développement, la fabrication et la commercialisation de produits de santé animale. Le CA par secteur d'activité se répartit comme suit : - animaux de compagnie (64,4%) : chiens et chats (94,9% du CA)... Show More Translate
undefined logo
ZTS
Zoetis
173.57
-0.03 (-0.02%)
Trade
MarketUpdates
Edited
$ZTS (Zoetis) Q3 2023 earnings report is expected to be released
2
NOV
REPORTS
Zoetis Q3 2023 earnings report is expected to be released before market open
Notify me
ZTS
ZTS
Zoetis
173.98
-0.03
(-0.02%)
Trade
Kanya Koesoemo
𝐃𝐚𝐢𝐥𝐲 𝐔𝐩𝐝𝐚𝐭𝐞 🚨 𝐏𝐞𝐫𝐟𝐨𝐫𝐦𝐚𝐧𝐜𝐞 | 𝟑𝟎-𝟎𝟖-𝟐𝟎𝟐𝟑 Portfolio +0.53% 🟢 $SPY +0.39% 🟢 🔼 $SPOT (Spotify Technologies SA) $MELI (MercadoLibre) 🔽 $NVO (Novo-Nordisk A/S SPONS ADR) $META (Meta Platforms Inc) 𝐔𝐩𝐜𝐨𝐦𝐢𝐧𝐠 𝐄𝐚𝐫𝐧𝐢𝐧𝐠𝐬 - 𝐔𝐩𝐜𝐨𝐦𝐢𝐧𝐠 𝐃𝐢𝐯𝐢𝐝𝐞𝐧𝐝𝐬 01-09:... Show More
Like CommentShare
null
.
Kanya Koesoemo
𝐃𝐚𝐢𝐥𝐲 𝐔𝐩𝐝𝐚𝐭𝐞 🚨 𝐏𝐞𝐫𝐟𝐨𝐫𝐦𝐚𝐧𝐜𝐞 | 𝟐𝟗-𝟎𝟖-𝟐𝟎𝟐𝟑 Portfolio +1.49% 🟢 $SPY +1.41% 🟢 🔼 $TSLA (Tesla Motors, Inc.) $MELI (MercadoLibre) 🔽 $LMT (Lockheed Martin Corporation) 𝐔𝐩𝐜𝐨𝐦𝐢𝐧𝐠 𝐄𝐚𝐫𝐧𝐢𝐧𝐠𝐬 - 𝐔𝐩𝐜𝐨𝐦𝐢𝐧𝐠 𝐃𝐢𝐯𝐢𝐝𝐞𝐧𝐝𝐬 01-09: $ZTS (Zoetis) $V (Visa) 𝐂𝐨𝐦𝐦𝐞𝐧𝐭𝐚𝐫𝐲 The... Show More
Like CommentShare
null
.

About Zoetis

Zoetis, Inc. is an animal health company that develops, manufactures, and markets animal health medicines, vaccines, and diagnostic products. The company, which was founded in 1952, is based in Parsippany, New Jersey. Zoetis operates in the United States and internationally. The company develops species-specific products for livestock such as cattle and sheep, pigs, poultry, fish, and companion animals that include cats, dogs, and horses. Zoetis vaccines and other biological preparations protect animals against diseases such as respiratory, gastrointestinal, and reproductive ailments. These medicines also induce immune-specific responses to counter diseases. The company's anti-infective drugs are designed to prevent, kill, or slow the growth of bacteria, fungi, protozoa, and parasiticides such as fleas, ticks, and worms. Other pharmaceutical products include pain killers and sedatives, antiemetic, reproductive, oncology, and dermatological therapeutics. Zoetis also manufactures and supplies portable blood and urine analyses systems and point-of-care diagnostic products. Additionally, the company offers biodevices, genetic tests, and precision livestock farming services. Zoetis customers include veterinarians, livestock producers, retailers, sales representatives, and other applicable distribution channels. The company is publicly listed on the NYSE under the ZTS ticker. Keep up to date with the ZTS share price by adding Zoetis, Inc. to your watchlist on eToro.
Kristin C. Peck, MBA
CEO
13.8K
Employees
1952
Founded
Parsippany, New Jersey, US
HQ
Show More

Upcoming Events

2
NOV
REPORTS
Zoetis Q3 2023 earnings report is expected to be released before market open

Analyst Forecast

Consensus
Moderate Buy
Price Target
202.50

ESG: A New Source of Insight

Get insight into a company's sustainability using ESG (environmental, social, and governance) scores.
0
100
61
Very High
Industry 
Avg. 47 
60
Environment
70
Social
52
Governance

Business Involvement Flags

People Also Bought